CPH vs. THCX, CRON, GUD, TLRY, ACB, WEED, FIRE, OGI, EPI, and ICC
Should you be buying Cipher Pharmaceuticals stock or one of its competitors? The main competitors of Cipher Pharmaceuticals include Hydropothecary (THCX), Cronos Group (CRON), Knight Therapeutics (GUD), Tilray Brands (TLRY), Aurora Cannabis (ACB), Canopy Growth (WEED), Supreme Cannabis (FIRE), Organigram (OGI), ESSA Pharma (EPI), and ICC Labs (ICC). These companies are all part of the "drug manufacturers - specialty & generic" industry.
Cipher Pharmaceuticals vs. Its Competitors
Cipher Pharmaceuticals (TSE:CPH) and Hydropothecary (CVE:THCX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations.
Cipher Pharmaceuticals has a net margin of 59.92% compared to Hydropothecary's net margin of 0.00%. Cipher Pharmaceuticals' return on equity of 17.93% beat Hydropothecary's return on equity.
1.4% of Cipher Pharmaceuticals shares are owned by institutional investors. 42.0% of Cipher Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Cipher Pharmaceuticals presently has a consensus target price of C$14.75, indicating a potential upside of 14.25%. Given Cipher Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Cipher Pharmaceuticals is more favorable than Hydropothecary.
Cipher Pharmaceuticals has higher revenue and earnings than Hydropothecary.
In the previous week, Cipher Pharmaceuticals had 1 more articles in the media than Hydropothecary. MarketBeat recorded 1 mentions for Cipher Pharmaceuticals and 0 mentions for Hydropothecary. Cipher Pharmaceuticals' average media sentiment score of 0.00 equaled Hydropothecary'saverage media sentiment score.
Summary
Cipher Pharmaceuticals beats Hydropothecary on 11 of the 11 factors compared between the two stocks.
Get Cipher Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for CPH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cipher Pharmaceuticals Competitors List
Related Companies and Tools
This page (TSE:CPH) was last updated on 7/17/2025 by MarketBeat.com Staff
